Getting the most information in the most ethical manner from investments in medical research is a primary goal for all who manage this type of financial appropriation, whether at the National Institutes of Health, the Department of Defense, or elsewhere. Clinical studies of prehospital trauma care, such as that published by Pusateri et al1 in this issue of JAMA Surgery, are particularly challenging (and expensive) because they require enrollment of patients with a waiver of informed consent and data that are difficult to collect and analyze. Several important features of the study by Pusateri et al1 should assure US taxpayers that, in this case, they got their money’s worth.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Rasmussen TE, Brosch LR. Getting Our Money’s Worth From Clinical Care Studies of Prehospital Trauma Care. JAMA Surg. Published online December 18, 2019. doi:10.1001/jamasurg.2019.5086
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: